Olympus reviewed the following literature titled "long slimmer metal stent is feasible and effective for endoscopic dual stent-by-stent placement in malignant hilar biliary stricture".Literature summary: the aim of this study was to evaluate the feasibility, efficacy, and safety of the new metal stent for palliative treatment of malignant hilar biliary strictures (mhbs).The technical success rate was 100%, with a mean procedure time of 43.7 ± 11.5 min.The clinical success was achieved in 44 patients (97.8%).Early adverse events included mild acute pancreatitis (n = 2) and cholangitis (n = 3).Later cholangitis occurred in 14 of the 45 patients due to stent occlusions.The median stent patency was 260 days (95% ci 228.3¿291.7).Stent malfunctions occurred in 23 of the 45 patients, and 15 of them received bilateral endoscopic plastic stents placements.The technical success for the re-intervention was 100% with the mean procedure time of 24.3 ± 4.5 min.The median overall survival of the whole group was 229 days (95% ci 171.2¿286.8).The long slimmer metal stent for bilateral endoscopic stent-by-stent placement proved to be safe, feasible, and effective for mhbs and facilitates endoscopic re-intervention as well type of adverse events/number of patients: mild acute pancreatitis - (2).Cholangitis - (3).Later cholangitis - (14).All pep cases were graded as mild and recovered in 1¿3 days after conservative management.The patients with acute cholangitis were treated with antibiotics without the need of additional endoscopic or percutaneous interventions.During a median follow-up period of 245.3 (46¿638) days, later cholangitis occurred in 14 of the 45 patients.Stent malfunctions occurred in 23 of the 45 patients.Six patients underwent ptbd in other hospitals.Two patients died of cholangitis.The remaining 15 of the 23 patients underwent endoscopic re-intervention in our center.The causes of stent malfunction included overgrowth (2/15), ingrowth (9/15), and sludge (4/15).Bilateral plastic stents were successfully inserted into both sides through the bilateral metal stents¿ lumen.This article includes 3 reports: patient identifier (b)(6): tjf-240.Patient identifier (b)(6): tjf-260v.Patient identifier (b)(6): kd-vc411q-0320.This report is 2 of 3 for patient identifier (b)(6): tjf-260v.
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.Please see the updates in h6 and h10.The device history record was unable to be reviewed for this device since the serial number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
|